Chemical Design and Pharmacokinetics Enable Precision Psychedelic Therapeutics
Abstract
Recent psychedelic patent activity highlights a strategic shift from experiential framing toward chemically and pharmacokinetically precise neurotherapeutics. Four recent patent applications collectively span solid-state control of psilocybin, exposure-shaped intramuscular and infusion-based dosing, and chemically diversified monoaminergic scaffolds with defined transporter and receptor pharmacology. Together, these disclosures outline a platform-level evolution toward reproducible, mechanism-informed psychedelic medicines.
Fields of Study & Subjects
Psychedelics and Drug Studies
Alkaloids: synthesis and pharmacology
Forensic Toxicology and Drug Analysis
Publication details
- Journal / source
- ACS Medicinal Chemistry Letters
- Volume
- 17
- Issue
- 2
- Pages
- 312–314
- Publication date
- 12 January 2026
- Language
- EN